Changes in PSA Kinetics Predict Metastasis-Free Survival in Men with PSA-Recurrent Prostate Cancer Treated with Non-Hormonal Agents: Combined Analysis of 4 Phase II Trials

類似資料

• Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with non-hormonal agents: Combined analysis of four phase-2 trials
  著者:: Suzman, Daniel L., 等
  出版事項: (2014)
• Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy
  著者:: Schweizer, M. T., 等
  出版事項: (2013)
• Lenalidomide Modulates IL-8 and Anti-Prostate Antibody Levels in Men with Biochemically Recurrent Prostate Cancer
  著者:: Zabransky, Daniel J., 等
  出版事項: (2011)
• The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
  著者:: Paller, CJ, 等
  出版事項: (2013)
• Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database
  著者:: Antonarakis, Emmanuel S., 等
  出版事項: (2010)